ABT Class Action Lawsuit Deadline November 7, 2022 Abbott Laboratories Lawsuit ABT Stock
ABT Class Action Lawsuit Deadline November 7, 2022 Abbott Laboratories Lawsuit ABT Stock
Blog Article
Levi & Korsinsky, LLP announces that a SMRF class action lawsuit has been filed on behalf of investors who purchased Sema4 Holdings, Corp. (SMRF) securities between March 14, 2022 and August 15, 2022. For more on the SMRF Lawsuit please contact us today.
According to the Sema4 Holdings, Corp. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
(1) there was a significant risk that Sema4 would reverse a material amount of previously recognized revenue that it could not recoup from third party payors; (2) the Company was experiencing declining selling prices for its reproductive health segment; (3) as a result of the foregoing, Sema4’s financial results would be adversely affected; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
TO LEARN MORE ABOUT THE ABT CLASS ACTION LAWSUIT https://www.zlk.com/pslra-1/sema4-lawsuit-loss-submission-form
If you suffered a loss in Sema4 Holdings, Corp. you have until November 7, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that here you serve as a lead plaintiff.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com